DYNE THERAPEUTICS INC. - COMMON STOCK
29.60
25-نوفمبر-24 11:50:13
15 متأخرة بدقائق
الأسهم
-0.10
-0.32%
نطاق اليوم
29.19 - 30.77
ISIN
N/A
المصدر
NASDAQ
-
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
12 نوفمبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
07 نوفمبر 2024 15:15:00 بحسب Nasdaq GlobeNewswire
-
09 أكتوبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
23 سبتمبر 2024 07:56:28 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Key Leadership Appointments
03 سبتمبر 2024 05:31:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
29 أغسطس 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
12 أغسطس 2024 16:10:00 بحسب Nasdaq GlobeNewswire
-
24 يونيو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
13 يونيو 2024 15:40:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
30 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
28 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
21 مايو 2024 19:39:57 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
20 مايو 2024 15:01:00 بحسب Nasdaq GlobeNewswire
-
19 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
02 مايو 2024 15:10:00 بحسب Nasdaq GlobeNewswire
-
27 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
27 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces CEO Transition
25 مارس 2024 06:30:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >